Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology - 1 Jan 2000

Cabuk Devrim, Yetimoglu Eylem, Simsek Turgay, Gacar Gulcin, Subasi Cansu, Canturk Zafer, Ercin Cengiz, Karaoz Erdal, Uygun Kazim

Abstract excerpt

PURPOSE: The purpose of this study was to investigate the correlation between the percentages of CD44+/CD24- cancer stem cells (CSCs) and the clinicopathological and prognostic factors in breast cancer patients. METHODS: Twenty three women who underwent surgery for breast cancer were enrolled in this study. The mean age of the patients was 46.65 years and 52% had early-stage disease. Tumor tissues obtained during...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD24 Antigen
Share to Hyaluronan Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mastectomy

Share to Mucin-1

Share to Neoplastic Stem Cells

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 27837613

Genes

MUC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors.PMID 27837613Read ↗

Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.Semantic proximity Read ↗

CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.Semantic proximity Read ↗

Are CD44+/CD24- cells the assumed cancer stem cells in breast cancer?Semantic proximity Read ↗

CD44+/CD24‑ phenotype predicts a poor prognosis in triple‑negative breast cancerSemantic proximity Read ↗

Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.Semantic proximity Read ↗

Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.Semantic proximity Read ↗

CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.Semantic proximity Read ↗

Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).Semantic proximity Read ↗

Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinomaSemantic proximity Read ↗

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.Semantic proximity Read ↗

Novel molecular regulators of breast cancer stem cell plasticity and heterogeneitySemantic proximity Read ↗

Cancer stem cells and their implication in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.